Skip to main content

Table 7 Clinical characteristics of CRC in different sites from Broad Institute’s GDAC Firehose

From: Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer

 

Rectum group

Colon group

p-value

Cases, n

41

176

–

Males, n

24

93

0.510

Age (years)

44.88 ± 14.26

43.90 ± 14.55

0.697

Vital status

8

42

0.551

Days to death (days)

599.88 ± 468.76

853.74 ± 806.69

0.395

NA

8

134

–

Days to last follow-up (days)

876.48 ± 691.48

995.50 ± 952.63

0.501

NA

8

42

–

Pathologic stage

 Stage I

4

22

0.698

 Stage II

15

74

 Stage III

15

48

 StageVI

6

24

 NA

1

8

–

Pathology T stage

 T1

2

4

0.757

 T2

4

23

 T3

30

125

 T4

5

24

Pathology N stage

 N0

19

104

0.062

 N1

12

50

 N2

9

22

 NX

1

0

Pathology M stage

 M0

31

120

0.279

 M1

6

24

 MX

3

31

 NA

1

1

–

  1. A total of 217 clinical samples with RNA-seq data from Broad Institute’s GDAC Firehose were included. The tables compiled the clinical characteristics of CRC in different sites from Broad Institute’s GDAC Firehose